A Comparison of Low Versus Standard Dose Pravastatin Therapy for the Prevention of Cardiovascular Events in the Elderly : The Pravastatin Anti-atherosclerosis Trial in the Elderly (PATE)-Reference-Cited by-同舟云学术

A Comparison of Low Versus Standard Dose Pravastatin Therapy for the Prevention of Cardiovascular Events in the Elderly : The Pravastatin Anti-atherosclerosis Trial in the Elderly (PATE)

Published:2001 Issue:2 Volume:8 Page:33-44
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:J Atheroscler Thromb

Author:

Ito Hideki,Ouchi Yasuyoshi,Ohashi Yasuo,Saito Yasushi,Ishikawa Toshitsugu,Nakamura Haruo,Orimo Hajime

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat1994/8/2/8_2_33/_pdf

Reference32 articles.

1. (1) Lipid Research Clinics Program : The lipid research clinics coronary primary prevention trial results ; reduction in incidence of coronary heart disease. JAMA, 251 : 351-364, 1984.

2. (2) Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, Maenpaa H, M5IkOnen M, Manttari M, Norola S, Pasternack A, Pikkarainen J, Romo M, SjOblom T, Nikkilä EA, and Helsinki Heart Study : Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med, 317 : 1237-1245, 1987

3. (3) Scandinavian Simvastatin Survival Study Group : Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease ; the Scandinavian Simvastatin Survival Study (4S). Lancet, 344 : 1383-1389, 1994

4. (4) Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, McKillop JH, and Packard CJ : The West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med, 333 : 1301-1307, 1995

5. (5) Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun CC, Davis BR, and Braunwald E, and The Cholesterol and Recurrent Events Trial Investigators : The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med, 335 : 1001-1009, 1996

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Promise of Primary Prevention in Older Adults;Journal of the American College of Cardiology;2023-10

2. Efficacy, safety and clinical outcome associated with statin use for primary prevention in Korean patients with low-density lipoprotein cholesterol level ≥ 190 mg/dL: A retrospective cohort study;PLOS ONE;2023-06-12

3. Dataset dependency of low-density lipoprotein-cholesterol estimation by machine learning;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;2023-06-05

4. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022;Journal of Atherosclerosis and Thrombosis;2023

5. Extent of Low-density Lipoprotein Cholesterol Reduction and All-cause and Cardiovascular Mortality Benefit: A Systematic Review and Meta-analysis;Journal of Cardiovascular Pharmacology;2022-08-24